Alexander A Yabrov
age ~93
from Princeton, NJ
- Also known as:
-
- Alex A Yabrov
- Alexander A Yabrou
- Phone and address:
-
70 Roper Rd, Princeton, NJ 08540
6099243325
Alexander Yabrov Phones & Addresses
- 70 Roper Rd, Princeton, NJ 08540 • 6099243325
- 15 Trowbridge St APT 4, Cambridge, MA 02138
- Boston, MA
- 70 Roper Rd, Princeton, NJ 08540 • 6097742030
Education
-
Degree:Graduate or professional degree
Emails
Name / Title
Company / Classification
Phones & Addresses
Paul M. Fleishman Company, A Limited Partnership
37 Jacquith Rd, Wilmington, MA 01887
Isbn (Books And Publications)
Us Patents
-
Method Of Enhancing Efficacy Of Electrical Apparatuses
view source -
US Patent:20100087323, Apr 8, 2010
-
Filed:Sep 30, 2008
-
Appl. No.:12/286257
-
Inventors:Alexander Yabrov - Princeton NJ, US
-
International Classification:H01L 39/02
H01J 25/00 -
US Classification:505200, 505150
-
Abstract:The present invention is a method of enhancing efficacy of electrical apparatuses by using the augmented velocity electrons.
-
Natural Mixture Of Type I And Type Ii Interferons
view source -
US Patent:44800320, Oct 30, 1984
-
Filed:Nov 13, 1980
-
Appl. No.:6/206401
-
Inventors:Alexander A. Yabrov - Princeton NJ
-
International Classification:C12P 2100
A61K 4502
C07G 700 -
US Classification:435 68
-
Abstract:Pharmaceutical compositions comprising a natural mixture of Type I and Type II interferons which are produced by induction with measles vaccine virus in leukocyte cells obtained from human donors immune to measles, and methods for the preparation of such pharmaceutical compositions.
-
Prophylaxis Or Treatment Of Interferon-Sensitive Diseases
view source -
US Patent:44605749, Jul 17, 1984
-
Filed:Jun 16, 1980
-
Appl. No.:6/159540
-
Inventors:Alexander A. Yabrov - Princeton NJ
-
International Classification:A61K 4502
-
US Classification:424 85
-
Abstract:Prophylaxis or treatment of interferon-sensitive diseases in a human is effected by the rectal or urogenital administration to a human of a liquid pharmaceutical composition of native human interferon (Types I and II), said liquid pharmaceutical composition not being clinically appropriate for intravenous or intramuscular injection.
-
Method For Determining Levels Of Cell-Mediated Immunity
view source -
US Patent:47881437, Nov 29, 1988
-
Filed:Apr 30, 1984
-
Appl. No.:6/605321
-
Inventors:Alexander A. Yabrov - Princeton NJ
Theodore Khavkin - Highland Park NJ -
International Classification:C12Q 102
-
US Classification:435 29
-
Abstract:A patient's level of cell-mediated immunity is determined by obtaining a blood sample from the patient, incubating cells from the sample in a tissue culture medium containing Concanavalin A, and observing the number of polykaryons produced or the number of nuclei per polykaryon or both to thereby determine the level of cell-mediated immunity of the hose from which the blood sample was obtained.
Youtube
Get Report for Alexander A Yabrov from Princeton, NJ, age ~93